Stay updated on AVA6000 in Solid Tumours Clinical Trial
Sign up to get notified when there's something new on the AVA6000 in Solid Tumours Clinical Trial page.

Latest updates to the AVA6000 in Solid Tumours Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded study sites in New York, Texas, and Washington and included Dr Jennifer Specht as Principal Investigator. Updated TNBC eligibility to allow any prior therapy with BRCA wild-type and removed the previous site list and the TNBC criteria restricting to up to 3 lines of prior therapy and BRCA PD-L1 negative.SummaryDifference0.7%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedSite revision updated from v3.3.1 to v3.3.2; no changes to trial content, eligibility criteria, locations, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page shows a cosmetic version update from Revision: v3.2.0 to Revision: v3.3.1 with no changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check47 days agoChange DetectedThe government funding/operating-status notice was removed from the page, a minor change that does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check61 days agoChange DetectedThe study page now shows updated AVA6000 trial details with a new title/description and recruitment status marked as Recruiting. The inclusion criteria and tumor-type details have been expanded and contact information has been updated.SummaryDifference1%

- Check90 days agoChange DetectedMajor update to the page content: adds a government-operating-status notice and bumps the version from v3.1.0 to v3.2.0.SummaryDifference2%

Stay in the know with updates to AVA6000 in Solid Tumours Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AVA6000 in Solid Tumours Clinical Trial page.